1. Home
  2. OPBK vs CDXS Comparison

OPBK vs CDXS Comparison

Compare OPBK & CDXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OPBK
  • CDXS
  • Stock Information
  • Founded
  • OPBK 2005
  • CDXS 2002
  • Country
  • OPBK United States
  • CDXS United States
  • Employees
  • OPBK N/A
  • CDXS N/A
  • Industry
  • OPBK Major Banks
  • CDXS Major Chemicals
  • Sector
  • OPBK Finance
  • CDXS Industrials
  • Exchange
  • OPBK Nasdaq
  • CDXS Nasdaq
  • Market Cap
  • OPBK 176.4M
  • CDXS 201.3M
  • IPO Year
  • OPBK 2018
  • CDXS 2010
  • Fundamental
  • Price
  • OPBK $13.65
  • CDXS $2.68
  • Analyst Decision
  • OPBK Hold
  • CDXS Buy
  • Analyst Count
  • OPBK 1
  • CDXS 2
  • Target Price
  • OPBK $18.00
  • CDXS $11.00
  • AVG Volume (30 Days)
  • OPBK 159.8K
  • CDXS 873.1K
  • Earning Date
  • OPBK 07-24-2025
  • CDXS 08-07-2025
  • Dividend Yield
  • OPBK 3.48%
  • CDXS N/A
  • EPS Growth
  • OPBK 0.92
  • CDXS N/A
  • EPS
  • OPBK 1.42
  • CDXS N/A
  • Revenue
  • OPBK $81,356,000.00
  • CDXS $49,815,000.00
  • Revenue This Year
  • OPBK $19.87
  • CDXS $12.77
  • Revenue Next Year
  • OPBK $10.60
  • CDXS $22.12
  • P/E Ratio
  • OPBK $9.72
  • CDXS N/A
  • Revenue Growth
  • OPBK 4.15
  • CDXS N/A
  • 52 Week Low
  • OPBK $9.45
  • CDXS $1.90
  • 52 Week High
  • OPBK $18.57
  • CDXS $6.08
  • Technical
  • Relative Strength Index (RSI)
  • OPBK 62.19
  • CDXS 58.42
  • Support Level
  • OPBK $11.52
  • CDXS $2.55
  • Resistance Level
  • OPBK $14.52
  • CDXS $2.91
  • Average True Range (ATR)
  • OPBK 0.43
  • CDXS 0.17
  • MACD
  • OPBK 0.22
  • CDXS 0.04
  • Stochastic Oscillator
  • OPBK 68.00
  • CDXS 66.90

About OPBK OP Bancorp

OP Bancorp is engaged in the general commercial banking business in Los Angeles, Orange, and Santa Clara Counties, California, Carrollton, Texas, and Las Vegas, Nevada. The Bank is focused on serving the banking needs of small- and medium-sized businesses, professionals, and residents with a particular emphasis on Korean and other ethnic minority communities. It operates with eleven full branches.

About CDXS Codexis Inc.

Codexis Inc is a provider of enzymatic solutions for efficient and scalable therapeutics manufacturing that leverages its proprietary CodeEvolver technology platform to discover, develop, and enhance novel, high-performance enzymes. Codexis enzymes solve challenges associated with small molecule pharmaceuticals manufacturing and nucleic acid synthesis. The Company is currently developing its proprietary ECO Synthesis manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. Codexis' enzymes can drive improvements such as higher yields, reduced energy usage and waste generation, improved efficiency in manufacturing and greater sensitivity in genomic and diagnostic applications. Geographically, it derives maximum revenue from the Americas.

Share on Social Networks: